# Sustainable Transition: Advancing a Managed Path to Domestic Financing in Indonesia

Indonesia is demonstrating how a carefully planned transition from Global Fund support to domestically financed health systems can be effectively delivered to protect health outcomes and sustain progress against HIV, TB and malaria.

The Global Fund supported a comprehensive analysis of investments made in Indonesia to identify transition pathways and assess risks associated with a full shift to domestic financing. The analysis drew on extensive stakeholder consultations, assessments of available fiscal space and a review of the policy and regulatory environment governing domestic financing institutions.

Indonesia’s malaria program is expected to transition from Global Fund support after the end of Grant Cycle 8, which finishes in 2029. The HIV and TB programs are scheduled to transition after the end of Grant Cycle 9, which finishes in 2032. The analysis identified critical areas requiring continued Global Fund support until the end of these transition timelines, including the procurement of essential, lifesaving medicines and diagnostics, as well as community-based health services. 

In March 2026, the Ministry of Health formally assumed leadership of the transition agenda, presenting a time-bound roadmap for a managed shift in financing, purchasing mechanisms and contracting models to ensure continuity of essential health services. Transition planning will build on existing national systems, distinguishing between activities that can be fully financed domestically in the near term and those that will require a phased or blended approach.

Through a clearly defined timeline, targeted technical assistance and strong collaboration between the Global Fund Secretariat, the Country Coordinating Mechanism, the Ministry of Health and other in-country partners, Indonesia is advancing a well-planned transition to domestic financing, grounded in sustainability and focused on maintaining quality and continuity of care.

Indonesia has been a Global Fund donor since 2022, pledging to both the Seventh and Eighth Replenishments, which is a testament to the country’s commitment to tackling HIV, TB and malaria globally and building strong and resilient health systems.